These findings indicate that modulation of TMPRSS2 expression through G-quadruplex structure stabilization in the gene promoter may be a novel anti-influenza strategy and this strategy may lead to developing new small molecule drugs against IAV. Here, TMPRSS2 is linked to influenza.